Aim To test the possibility of using a discrete choice experiment model, on a national level in adolescents with Type 1 diabetes, in order to obtain a better understanding of drivers of and barriers to diabetes self-care.
Introduction
Appropriate self-management of Type 1 diabetes is essential for long-term prognosis. Knowing more about how teenagers manage their disease, and their wishes and attitudes towards treatment aspects will enable improvements in support by the diabetes team.
The discrete choice experiment is a stated preference technique that can be used to elicit preferences for healthcare interventions, services and policies. The discrete choice experiment questions ask respondents to choose their preferred alternative among pairwise comparisons. Each alternative differs with respect to the combinations of treatment attributes/characteristics and their levels. It is assumed that individuals will choose the alternative that offers the combination of attribute levels that has the highest value/utility to them. The observed choices of different combinations of attribute levels can then be used to estimate the relative importance of the various treatment characteristics [1] . An overview of the methodology and its application in health is provided by Ryan et al. [2] .
In 2013, a national survey of adolescents with Type 1 diabetes, Teenagers On Diabetes Sweden (TODS), was carried out in Sweden [3] . The purpose was in part to derive and analyse the preferences for diabetes treatment aspects. A discrete choice experiment was included in the survey in order to analyse how adolescents trade off different attributes of diabetes treatment.
Discrete choice experiments often include a price attribute in order to obtain preference estimates in the form of willingness-to-pay estimates. In the context of teenagers, it was deemed unrealistic and unethical to include hypothetical financial considerations. Instead, we chose to look at the implied relative importance of the attribute levels. Moreover, we included HbA 1c as an attribute with three levels. This enables a quantification of preferences in terms of marginal rate of substitution between a given treatment effect or administration effect attribute and glycaemic control, measured as HbA 1c , or put in another way: how much respondents were willing to trade off glycaemic control in order to receive a given treatment or administration effect.
Methods

Study design and target population
A focus group discussion among adolescents with diabetes identified important aspects of living with diabetes. A random sample of 14 adolescents of both sexes, aged 15 to <18 years, were invited to an informal, semi-structural discussion led by a person trained in interview technique. As a result of the issues raised, a questionnaire was constructed, which in turn was tested for relevance and accuracy on another group of eight individuals. After feedback, the final form was created, whereby the most important elements were prioritized to form the discrete choice experiments.
For access to the large group of adolescents of interest in this study, the Swedish paediatric diabetes quality registry SWEDIABKIDS was used. The register includes data on almost all (~99%) children and adolescents (aged <18 years) with diabetes in Sweden. The register has been webbased since 2008 and has the status of a national quality register [5] .
Following ethical approval, all adolescents in the SWE-DIABKIDS registry with Type 1 diabetes born in 1995, 1996 and 1997 (i.e. aged between 15 and <18 years) were sent an invitation by post to complete an online questionnaire, accessible through a website designed specifically for the study (www.tods-study.se). A total of 2112 eligible teenagers were identified and a second letter was sent to remind nonrespondents. The data were collected in the period May to December 2013. The study sample was completed after two letters (Fig. 1 ).
Ethical considerations
The study was approved by the regional ethical review board in Gothenburg and was performed in accordance with the Declaration of Helsinki.
Discrete choice experiment
Two discrete choice experiment preference elicitation modules were applied, as described below.
The first module addressed the clinical effects of the insulin treatment (frequency of hypo-and hyperglycaemic events, weight change and change in mean HbA 1c level). The second module considered the administration of the diabetes treatment (plasma glucose testing frequency, flexibility regarding injections, hypothetical device improvements, and change in mean HbA 1c level).
All treatment attributes were introduced to respondents in questions preceding the discrete choice experiment modules. Examples of the discrete choice experiment questions are given in Tables S1 and S2 , and Figures S1 and S2 in the Supporting Information.
Treatment effects module
All attributes and attribute levels of the treatment effects module are shown in Table 1 .
HbA 1c level
The HbA 1c attribute can take on three levels: 55 mmol/mol (7.2%), 65 mmol/mol (8.1%) and 75 mmol/mol (9.0%), arbitrarily corresponding to good, medium and poor glycaemic control, respectively. The chosen levels were based on international agreement on optimal, suboptimal and highrisk HbA 1c level at the time of the study [6] .
Weight change
Weight is a concern for some adolescents. Insulin treatment may result in weight gain, and non-compliance can be used to lose weight. Deliberate under-dosing or omission of insulin because of weight concerns is evident, especially in young women [7] , and is a cause of development of vascular complications [8] ; therefore, weight was included in the preference elicitation to explore how this attribute of treatment is prioritized relative to other components.
Hypoglycaemia
Hypoglycaemia [defined as blood glucose <4 mmol/l (<72 mg/dl)] is a serious concern for people with diabetes [9] . Achieving good glycaemic control might be associated with a higher risk of hypoglycaemia [10] , and fear of hypoglycaemia can be a severe barrier to achieving optimal What's new?
• This national study is the first to describe the possibility of using a discrete choice experiment model to analyse the lived experiences and preferences for treatment in adolescents aged 15-18 years with Type 1 diabetes.
• All attributes were significant predictors of choice, implying that respondents of both sexes cared about all the described treatment aspects.
• Avoiding weight gain and even achieving weight loss were the most important aspects among female respondents. They were willing to trade off a substantial level of glycaemic control to avoid a weight gain.
metabolic control [11, 12] . To assess the relative importance of frequency of non-severe hypoglycaemic events ('hypos') in treatment choices, an attribute with varying levels of hypoglycaemic event frequency was included.
Hyperglycaemia
Hyperglycaemia can be defined as blood glucose >10 mmol/l (>180 mg/dl) and is a major cause of poor metabolic control [13, 14] .
Treatment administration module
All attributes and attribute levels of the treatment administration module are shown in Table 2 .
HbA 1c level
The HbA 1c attribute can take on the same three levels as for the HbA 1c attribute in the first discrete choice experiment module addressing the treatment effects. 
Blood glucose testing
Blood glucose testing was reported among participants in the focus groups as being very inconvenient. Inclusion of this attribute was intended to help explore how patients trade off blood glucose testing against glycaemic control.
Flexibility regarding basal insulin
Insulin products differ in their flexibility with regard to timing; therefore, we explored how this affected the treatment preferences of adolescents.
Possible device improvements
The focus group interviews revealed a desire to obtain more convenient instruments. Possible improvements, such as reduced size or ability to communicate with a mobile phone app, were chosen on the basis of the focus group talks and have no relation to existing or known potential products.
Design selection
A full factorial choice design would give rise to (3*3*4*3*2) 2 and (3*3*3*3) 2 number of attribute combinations for the two modules, respectively. As is common practice, a selection of choice sets was made on the basis of statistical efficiency. The efficient design optimization process was carried out in NGENE [15] , constructing an unlabelled Bayesian D-efficient design in accordance with good practice guidelines [16] . To cover a larger spectrum of the total number of possible choice sets/scenarios, while not overburdening the respondents with questions, we blocked the respondents into four randomly assigned blocks, each of which included six choice sets for each discrete choice experiment module. The design practices used in the present study are common in the health economics preference literature and are in line with the practices described in guidelines [16] .
Test questions
We included qualifying questions to elaborate on the level of confidence in the respondents' answers and asked whether respondents felt certain about their answers. If not, a followup question was put to elicit an explanation for the uncertainty. Respondents who were uncertain in their answers because they did not understand the questions or were unwilling to consider the options were excluded. To ensure that respondents understood the concept of the choice exercises, a test question was included. According to standard practice, respondents who failed the test question were excluded from the study [17, 18] . Table S3 in the Supporting Information gives an overview of the exclusion criteria.
Statistical analysis
We examined whether the included attributes and their levels were significant determinants in the choice of preferred treatment alternative. We considered indications of the effects, i.e. whether attributes and level changes are perceived as desirable or undesirable. Further, we assessed the relative importance of the treatment features by examining how participants traded them against each other, in particular, how they traded off the effects against glycaemic control as measured by HbA 1c .
Using the conditional logit model, the probability of choosing an alternative j from n i choices in scenario i can be defined as:
where there are n i =2 possible choices in each scenario,C i [18, 19] . We assumed linear utility of the HbA 1c level. This assumption enabled us to use the HbA 1c as a scaling Since the marginal rate of substitution to HbA 1c was calculated as the ratio between two stochastic variables, confidence intervals (CIs) could not be derived directly from the parameter estimates of the conditional logit estimations; therefore, we adopted a bootstrapping approach to obtain a 95% CI. We carried out 10 000 iterations, as recommended by Barker [20] .
We stratified according to gender to see whether preferences for treatment effects, e.g. weight effects, differ between genders. We also stratified according to treatment regimen (pump vs pen) to allow for different preferences for treatment administration, e.g. testing and injection options. The attributes regarding type of basal injection will be explicitly analysed only for pen users.
Additionally, we compared included respondents with non-respondents using data from the SWEDIABKIDS registry by calculation of the duration of diabetes for each individual as the time between the first entry into the registry and the survey start date. For each individual, the individual' age at the survey start date was used. For respondents, the HbA 1c value included was the latest registered HbA 1c measurement prior to survey completion. For non-respondents, the latest registered HbA 1c measurement before the survey end date was used. The chi-squared test and t-test were used to examine differences in background characteristics between respondents and non-respondents.
All attributes were dummy-coded, except the HbA 1c attribute, which was treated as a continuous variable. Pvalues <0.05 were considered statistically significant. All statistical analyses were carried out using SAS 9.4.
Results
Sample
A total of 507 individuals initiated the questionnaire. Fiftyfour did not complete the survey, resulting in 453 complete responses. Eleven respondents failed the test question, and a further 11 respondents failed the uncertainty criteria. This resulted in 431 valid responses for the analyses of preferences. The data collection flow is illustrated in Fig. 1 .
The characteristics of the respondents were compared with those of the total population in terms of gender, age, HbA 1c and duration of diabetes (Table 3 ). The included respondents were not statistically different from non-participants in terms of age and duration of diabetes; however, a higher percentage of the population that entered the study were female than in the non-respondent population, and the participants had (on average) significantly lower HbA 1c values.
Preferences for treatment effects
All attributes were significant predictors of choice for both male and female respondents, implying that respondents cared about all the described treatment aspects ( Table 4 ). The signs of the coefficients showed that, as expected, a greater number of non-severe hypoglycaemic events (day and night) was undesired, as were hyperglycaemic events and weight gain. Figure 2 shows the marginal rate of substitution between the various treatment effects and HbA 1c level (mmol/mol). The results can be interpreted as the relative valuation of the attribute compared with HbA 1c , i.e. the willingness-to-trade HbA 1c units for the various effects. The thin lines illustrate the 95% CIs produced by bootstrapping. Formal t-tests are shown in Table S4 .
There was a considerable gender gap regarding preference for weight changes. Avoiding weight gain and even achieving weight loss were the most important aspects to female respondents (Table 4) . They were willing to trade off a substantial level of glycaemic control [13 mmol/mol (1.2%)] to avoid a weight gain of 3 kg, and were willing to trade off 4 mmol/mol (0.4%) to achieve a weight loss. For male respondents, the preference for avoiding a weight gain was more moderate and weight loss was undesired.
Preferences for other aspects showed greater similarity between the two genders. Avoiding night-time hypoglycaemic events was approximately three times as important as avoiding a daytime hypoglycaemic event. Avoiding one hyperglycaemic event was more important than having one fewer daytime hypoglycaemic event per week and was somewhat more important for male than for female respondents, although the CIs were overlapping (Fig. 2) . 
Preferences for treatment administration
All included attributes were significant predictors of choice and revealed expected signs of the coefficients. A higher number of blood glucose tests per day was undesired (although this effect was only borderline significant for pump users); having fewer injections was desired, and the hypothetical equipment improvements were desired (Table 5 ). Figure 3 shows the implied relative valuation of the administration attributes and HbA 1c (mmol/mol) for pump users (n=209) and pen users (n=222), respectively. Formal t-tests are shown in Table S5 .
Pen users preferred fewer injections and put equal value on changing from two injections at a fixed time to one injection at a fixed time. The most important aspect of insulin administration was to improve from two fixed-time injections to one flexible injection.
Pump users found that equipment that can communicate with an app was a significant improvement, whereas pen users put greater emphasis than pump users on reduced size of equipment.
Discussion
Good glycaemic control and the lowest possible glycaemic variability are not the only features of treatment that adolescents deem important. All the investigated attributes have a statistically significant influence on the preferred treatment option. Adolescents of both genders did recognize the importance of good glycaemic control even though shortterm benefits could wipe out the more long-term wishes for avoiding complications. In practice, a young person may trade off a more optimal HbA 1c level against avoiding shortterm inconvenience caused by, for example, impractical devices with regard to size and too many finger-pricks for plasma glucose monitoring. A significant wish to avoid daytime episodes of non-severe hypoglycaemia indicated that the social burden related to insulin treatment was strong; for example, embarrassment caused by even a non-severe hypoglycaemic event occurring during the school day [21] .
The most striking key finding, however, was the wish to avoid even a relatively modest weight gain of 3 kg in females, even if this would lead to poor glycaemic control. This confirms the driver of insulin omission and eating disturbances that is described in many studies in young women [21] . Dysfunctional eating habits and sedentary lifestyle need to be researched further. It is important to have regular discussion at the outpatient clinic about how insulin can be used without putting on extra weight.
On a group level, adolescents have less favourable glycaemic control than do children [22] . In puberty, there is a natural drive for independence. It has been shown that more slowly emerging adulthood in modern society may delay mature, responsible diabetes self-care by a decade [23] . Moreover, the adolescent with neurocognitive difficulties as well as diabetes, sometimes described as the 'triple troubled teenager', also faces the challenges of less ageappropriate cognitive development [24] . In Sweden, HbA 1c levels are gradually decreasing, but adolescents still have higher HbA 1c levels in comparison with younger children [25] . In 2016, the mean HbA 1c value for individuals aged 0- 18 years was 57 mmol/mol (7.4%), whereas in 2013 the corresponding mean HbA 1c value was 59 mmol/mol (7.5%).
In the age group of the present study, 15-18 years, a mean HbA 1c of 59 mmol/mol (7.5%) was reached in 2016, whereas in 2013, when the present study was conducted, the corresponding mean value was 64 mmol/mol (8.0%).
The big clinical treatment difference between those results, 3 years apart, was the breakthrough in use of modern techniques such as continuous glucose monitoring and flash glucose monitoring, which in 2016 was used by approximately 80% of paediatric diabetes patients in Sweden. When the present study was performed in 2013, the use of continuous glucose monitoring/flash glucose monitoring was less common, which explains why it was not included in the discrete choice experiment. The results do, however, indicate the importance of constructing user-friendly equipment, particularly regarding size and design.
A weakness of the present study is that, although the dataset was large, the number of respondents did not allow meaningful subdivision according to both gender and treatment type (pump vs pen). For treatment effects, it turned out that gender differences made stratification along gender lines important, whereas the treatment administration aspects were stratified according to treatment type. To truly generalize the results of the present study to the whole population of adolescents age 15 to <18 years in Sweden, a repeated national, large-scale study including more participants would be needed.
The discrete choice experiment method applied in the present study illustrated a quantification of how important certain treatment characteristics are to adolescents with Type 1 diabetes. The responses highlight useful indications of the aspects adolescents would prioritize given a real-life dilemma, pointing out possible strategies in the delivery of support provided by the caregivers.
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